Index Ventures and Amunix Invest in Diartis Pharmaceuticals. Diartis Pharmaceuticals, Inc., a newly founded biotechnology company, announced today that it has received initial funding from Index Ventures, Amunix Inc., a U.S. based biotechnology company, and private investors.
Other details on
www.marketwire.com/press-release/Index-Ventures-and-Amunix-Invest-in-Diartis-Pharmaceuticals-1396681.htm
No comments:
Post a Comment